Foundation Medicine and Bristol Myers Squibb Expand Collab on CDx Development
Foundation Medicine and Bristol Myers Squibb are developing the FoundationOne CDx as a companion diagnostic for repotrectinib.
Read MorePosted by Andy Lundin | Apr 11, 2023 | Cancer |
Foundation Medicine and Bristol Myers Squibb are developing the FoundationOne CDx as a companion diagnostic for repotrectinib.
Read MorePosted by Andy Lundin | Apr 11, 2023 | Company News |
Centogene has extended its partnership with Takeda to diagnose patients with lysosomal storage disorders (LSDs).
Read MorePosted by Andy Lundin | Apr 10, 2023 | Sexually Transmitted Diseases |
A quick diagnostic test developed by a Washington State University researcher may help curb the prevalent STI Trichomonas vaginalis.
Read MorePosted by Andy Lundin | Apr 6, 2023 | Colorectal |
Guardant Health and Ohio State University will evaluate patient compliance with a blood-based test for colorectal cancer (CRC) screening.
Read MorePosted by Andy Lundin | Apr 6, 2023 | Covid 19 |
Lucira Health announced the nationwide launch of its breakthrough Lucira COVID-19 & Flu Home Test in the United States.
Read More